Drug Approval | November 24, 2021
U.S. FDA approves first treatment for drug-resistant post-transplant infection
The approval is for Cytomegalovirus, a type of Herpes virus
The approval is for Cytomegalovirus, a type of Herpes virus
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
Carestream equipment is highly recommended for its imaging quality
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
Second interchangeable biosimilar product approved by agency
_256_384.jpg)
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Subscribe To Our Newsletter & Stay Updated
